Alpha 2.0
Login Register
» Articles » PMID: 7086673

Stereoselective Metabolism and Disposition of the Enantiomers of Mephenytoin During Chronic Oral Administration of the Racemic Drug in Man

Overview
Journal J Pharmacol Exp Ther
Specialty Pharmacology
Date 1982 Jun 1
PMID 7086673
Citations 10
Authors
A Kupfer
P V Desmond
S Schenker
R A Branch
Affiliations
Soon will be listed here.
Citing Articles

A model based assessment of the CYP2B6 and CYP2C19 inductive properties by artemisinin antimalarials: implications for combination regimens.

Elsherbiny D, Asimus S, Karlsson M, Ashton M, Simonsson U J Pharmacokinet Pharmacodyn. 2008; 35(2):203-17.

PMID: 18350255 DOI: 10.1007/s10928-008-9084-6.

Clinical significance of the cytochrome P450 2C19 genetic polymorphism.

Desta Z, Zhao X, Shin J, Flockhart D Clin Pharmacokinet. 2002; 41(12):913-58.

PMID: 12222994 DOI: 10.2165/00003088-200241120-00002.

Pharmacogenetics of mephenytoin: a new drug hydroxylation polymorphism in man.

Kupfer A, Preisig R Eur J Clin Pharmacol. 1984; 26(6):753-9.

PMID: 6489416 DOI: 10.1007/BF00541938.

Polymorphic debrisoquine and mephenytoin hydroxylation in patients with pulmonary hypertension of vascular origin after aminorex fumarate.

Saner H, GURTNER H, Preisig R, Kupfer A Eur J Clin Pharmacol. 1986; 31(4):437-42.

PMID: 3816924 DOI: 10.1007/BF00613521.

Family studies of mephenytoin hydroxylation deficiency.

Inaba T, Jurima M, KALOW W Am J Hum Genet. 1986; 38(5):768-72.

PMID: 3717162 PMC: 1684828.